Jim Simons Amneal Pharmaceuticals, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 532,730 shares of AMRX stock, worth $3.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
532,730
Previous 207,800
156.37%
Holding current value
$3.38 Million
Previous $1.26 Million
155.99%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AMRX
# of Institutions
178Shares Held
107MCall Options Held
330KPut Options Held
81.9K-
Vanguard Group Inc Valley Forge, PA13.7MShares$87.2 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$78.3 Million1.57% of portfolio
-
Fosun International LTD12.3MShares$78.2 Million54.23% of portfolio
-
Rubric Capital Management LP New York, NY9.54MShares$60.6 Million1.97% of portfolio
-
Black Rock Inc. New York, NY9.16MShares$58.2 Million0.0% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $961M
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...